Health Care & Life Sciences » Biotechnology | Cleveland BioLabs Inc.

Cleveland BioLabs Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
10,354.00
3,104.00
19,619.70
15,245.50
8,791.90
4,121
Total Accounts Receivable
458.40
267.20
631.10
352.70
554.50
251.80
Other Current Assets
344.40
174.20
442.60
289.80
233.60
103.40
Total Current Assets
11,156.80
3,545.30
20,693.40
15,887.90
9,580.00
4,476.30
Net Property, Plant & Equipment
457.90
244.50
123.00
37.40
18.60
27.70
Total Investments and Advances
2,921.70
5,968.20
37.70
-
-
-
Other Assets
159.20
56.10
26.60
30.60
30.70
30.40
Total Assets
14,695.60
9,814.20
20,880.60
15,955.90
9,629.30
4,534.40
ST Debt & Current Portion LT Debt
435.20
2,648.50
-
-
-
Accounts Payable
794.40
1,057.70
197.10
336.40
201.40
Other Current Liabilities
4,756.20
2,822.80
5,645.60
2,772.70
2,012.00
Total Current Liabilities
5,985.80
6,529.10
5,842.80
3,109.10
2,213.40
Long-Term Debt
7,128.90
1,499.10
-
-
-
Other Liabilities
-
-
-
-
7.50
Total Liabilities
13,114.70
8,028.10
5,842.80
3,109.10
2,220.90
Common Equity (Total)
9,522.90
1,607.40
9,888.20
7,524.00
2,199.70
Total Shareholders' Equity
9,522.90
1,607.40
9,888.20
7,524.00
2,199.70
Total Equity
1,581.00
1,786.10
15,037.90
12,846.80
7,408.40
Liabilities & Shareholders' Equity
14,695.60
9,814.20
20,880.60
15,955.90
9,629.30
Accumulated Minority Interest
11,103.90
3,393.50
5,149.70
5,322.80
5,208.60

About Cleveland BioLabs

View Profile
Address
73 High Street
Buffalo New York 14203
United States
Employees -
Website http://www.cbiolabs.com
Updated 07/08/2019
Cleveland BioLabs, Inc. is a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702.